These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29270124)

  • 1. Enhancing the Promise of Drug Repositioning through Genetics.
    Pritchard JE; O'Mara TA; Glubb DM
    Front Pharmacol; 2017; 8():896. PubMed ID: 29270124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
    Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
    BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of
    Wang YF; Zhang Y; Zhu Z; Wang TY; Morris DL; Shen JJ; Zhang H; Pan HF; Yang J; Yang S; Ye DQ; Vyse TJ; Cui Y; Zhang X; Sheng Y; Lau YL; Yang W
    Ann Rheum Dis; 2018 Jul; 77(7):1078-1084. PubMed ID: 29625966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale computational drug repositioning to find treatments for rare diseases.
    Govindaraj RG; Naderi M; Singha M; Lemoine J; Brylinski M
    NPJ Syst Biol Appl; 2018; 4():13. PubMed ID: 29560273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turning genome-wide association study findings into opportunities for drug repositioning.
    Lau A; So HC
    Comput Struct Biotechnol J; 2020; 18():1639-1650. PubMed ID: 32670504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connecting genetics and gene expression data for target prioritisation and drug repositioning.
    Ferrero E; Agarwal P
    BioData Min; 2018; 11():7. PubMed ID: 29881461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genomics-based systems approach towards drug repositioning for rheumatoid arthritis.
    Xu R; Wang Q
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):518. PubMed ID: 27557330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapeutics for coronary artery disease from genome-wide association study data.
    Grover MP; Ballouz S; Mohanasundaram KA; George RA; Goscinski A; Crowley TM; Sherman CD; Wouters MA
    BMC Med Genomics; 2015; 8 Suppl 2(Suppl 2):S1. PubMed ID: 26044129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial vezatin and its association with endometriosis risk.
    Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
    Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GREP: genome for REPositioning drugs.
    Sakaue S; Okada Y
    Bioinformatics; 2019 Oct; 35(19):3821-3823. PubMed ID: 30859178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision drug repurposing via convergent eQTL-based molecules and pathway targeting independent disease-associated polymorphisms.
    Vitali F; Berghout J; Fan J; Li J; Li Q; Li H; Lussier YA
    Pac Symp Biocomput; 2019; 24():308-319. PubMed ID: 30864332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translating GWAS findings into therapies for depression and anxiety disorders: gene-set analyses reveal enrichment of psychiatric drug classes and implications for drug repositioning.
    So HC; Chau CK; Lau A; Wong SY; Zhao K
    Psychol Med; 2019 Dec; 49(16):2692-2708. PubMed ID: 30569882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug repositioning: computational approaches and research examples classified according to the evidence level.
    Vogrinc D; Kunej T
    Discoveries (Craiova); 2017 Jun; 5(2):e75. PubMed ID: 32309593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of current trends in computational drug repositioning.
    Li J; Zheng S; Chen B; Butte AJ; Swamidass SJ; Lu Z
    Brief Bioinform; 2016 Jan; 17(1):2-12. PubMed ID: 25832646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.
    Ruderfer DM; Charney AW; Readhead B; Kidd BA; Kähler AK; Kenny PJ; Keiser MJ; Moran JL; Hultman CM; Scott SA; Sullivan PF; Purcell SM; Dudley JT; Sklar P
    Lancet Psychiatry; 2016 Apr; 3(4):350-7. PubMed ID: 26915512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel disease syndromes unveiled by integrative multiscale network analysis of diseases sharing molecular effectors and comorbidities.
    Li H; Fan J; Vitali F; Berghout J; Aberasturi D; Li J; Wilson L; Chiu W; Pumarejo M; Han J; Kenost C; Koripella PC; Pouladi N; Billheimer D; Bedrick EJ; Lussier YA
    BMC Med Genomics; 2018 Dec; 11(Suppl 6):112. PubMed ID: 30598089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repositioning for diabetes based on 'omics' data mining.
    Zhang M; Luo H; Xi Z; Rogaeva E
    PLoS One; 2015; 10(5):e0126082. PubMed ID: 25946000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational and experimental advances in drug repositioning for accelerated therapeutic stratification.
    Shameer K; Readhead B; Dudley JT
    Curr Top Med Chem; 2015; 15(1):5-20. PubMed ID: 25579574
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.